Pharma Reviews: Things should normalise for pharma sector from FY20-21: S Ramesh, Lupin

ET Now: Indian pharma has hit a speed breaker and a solid one at that, something that has really stalled things for a while with the USFDA relations ...
Read more: Things should normalise for pharma sector from FY20-21: S Ramesh, Lupin